GlassScriptPhysician profile
Charu Gupta
NPI 1689834418
$956.27
in general payments reported to CMS, 2019-2025
14 companies · $280 in 2025
The $280 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10.53 · 2020: $29.89 · 2021: $24.27 · 2022: $280 · 2023: $174 · 2024: $158 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $611.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $611.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $252.38 | 2020-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Cvrx, INC. | $248.65 | 2022-2025 | Barostim Neo System |
| Nuwellis, INC. | $132.45 | 2022 | |
| Novo Nordisk INC | $57.25 | 2022-2024 | Wegovy |
| Abiomed | $40.53 | 2023 | Impella |
| Pfizer INC. | $33.75 | 2024 | |
| Alnylam Pharmaceuticals INC. | $27.30 | 2023 | Onpattro |
| Merck Sharp & Dohme LLC | $26.86 | 2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $25.66 | 2025 | Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $24.93 | 2024 | |
| Janssen Pharmaceuticals, INC | $24.27 | 2021 | |
| Medtronic, INC. | $23.74 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.65 | 2019-2023 | Lifevest |
| Scpharmaceuticals INC. | $18.85 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charu Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.